Genesee Scientific Acquires Jade Scientific

LLR Partners Makes Growth Investment in Genesee Scientific

October 19, 2021

Medical Devices

LLR Partners completed a growth investment in Genesee Scientific, a San Diego–based manufacturer and distributor of life-science consumables and laboratory equipment. The partnership will fund expansion of Genesee's product portfolio and scaling of its national footprint; Audax Private Debt provided unitranche financing to support the transaction.

Lakelet Capital Acquires GenTech Scientific

September 30, 2020

Industrial Services

Buffalo-based private equity firm Lakelet Capital has completed an investment to support the buyout of GenTech Scientific, a refurbisher, reseller, and servicer of analytical laboratory instrumentation based in Arcade, New York. The investment provides growth capital to enhance operations, extend geographic reach, and expand solution offerings; Lakelet also installed Michael Lippa as CEO and worked with GenTech founder Clair Bragg on the transition.

L Squared Capital Partners / GSI Group Acquires Globe Scientific

April 28, 2022

Manufacturing

L Squared Capital Partners has acquired Globe Scientific and folded it into its GSI Group Holdings platform as the platform’s third add-on. Globe Scientific, a US-based maker and distributor of laboratory plasticware, glassware and benchtop equipment, will be integrated to expand GSI Group’s product portfolio, distribution footprint and reach into biopharma, diagnostics and academic research markets.

Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)

October 4, 2022

Biotechnology

Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.

Vantage Specialty Chemicals (H.I.G.-backed) Acquires JEEN International and BotanicalsPlus

March 1, 2022

Manufacturing

Vantage Specialty Chemicals, a portfolio company of H.I.G. Capital, has acquired JEEN International Corporation and BotanicalsPlus, Inc. The add-on strengthens Vantage’s personal care ingredients capabilities by adding JEEN’s botanical extracts, specialty actives and rapid formulation services; JEEN founders Adam and Jeanne Perle will join Vantage and remain invested.

Genesis Drug Discovery & Development (GD3) Acquires JSS Medical Research

May 10, 2023

Healthcare Services

Genesis Drug Discovery & Development (GD3), a member of Genesis Global Group (GGG), has acquired Montreal-headquartered JSS Medical Research to expand GD3's clinical services and create a more vertically integrated drug research and development platform. The acquisition adds JSS's clinical trial management, biostatistics, data management, medical writing and safety services to GD3/GGG's existing discovery and development capabilities, supporting broader geographic reach and enhanced end-to-end offerings for pharmaceutical, biotechnology and medical device clients.